Latest Breaking News On - Pipeline clinical program - Page 1 : comparemela.com

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares - Bionomics (NASDAQ:BNOX), Cybin (AMEX:CYBN)

NY Mets owner billionaire Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company Bionomics Limited (NASDAQ: BNOX) through his Point72 asset management firm, again showing support for the biopharma sector.

United statesSteve cohenBionomics limitedPipeline clinical programAustralian securities exchangeFrankfurt stock exchange fraFrankfurt stock exchangeAmerican depositary sharesOne step closer to beingSocial anxiety disorderTrack designations

Portage Biotech Announces Results for Fiscal Quarter Ended September 30, 2022

Portage Biotech Announces Results for Fiscal Quarter Ended September 30, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRelationsgwen schankerRelationschuck padalaAmerican society of clinical oncologyOwners of the companyMerck coPortage biotech incClinical development goals on producing nine phaseLincoln park capital fundCompany annual report on formDevelopment agreementSociety for immunotherapy of cancerDevelopment committeeMerck sharp dohme corpPipeline clinical programNational cancer institute collaboration research

Portage Biotech Announces Results for Fiscal Quarter Ended

Updated Data on Phase 1/2 Trial Evaluating PORT-2 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting Clinical.

United statesDevelopment agreementSociety for immunotherapy of cancerAmerican society of clinical oncologyDevelopment committeeMerck coPortage biotech incClinical development goals on producing nine phaseMerck sharp dohme corpLincoln park capital fundPipeline clinical programNational cancer institute collaboration researchUpdated dataClinical collaboration agreement enteredFocused clinical development goalsProducing nine phase